Eliana Clark

Insider Reports History

Entity
Individual
Location
C/O Intellia Therapeutics, Inc., 40 Erie Street, Suite 130, Cambridge, MA
Signature
/s/ James Basta, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eliana Clark:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Intellia Therapeutics, Inc. EVP, Chief Technical Officer Common Stock 71.5K $1.64M $22.93 Jul 1, 2024 Direct
Intellia Therapeutics, Inc. EVP, Chief Technical Officer Stock Option (right to buy) 45.1K Mar 1, 2024 Direct

Insider Reports Filed by Eliana Clark

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NTLA Intellia Therapeutics, Inc. Jul 1, 2024 1 -$9.29K 4 Jul 3, 2024 EVP, Chief Technical Officer
NTLA Intellia Therapeutics, Inc. Mar 1, 2024 3 -$20K 4 Mar 5, 2024 EVP, Chief Technical Officer
NTLA Intellia Therapeutics, Inc. Jan 3, 2024 2 -$136K 4 Jan 5, 2024 EVP, Chief Technical Officer
NTLA Intellia Therapeutics, Inc. Jul 3, 2023 1 -$14.6K 4 Jul 6, 2023 EVP, Chief Technical Officer
NTLA Intellia Therapeutics, Inc. Jun 20, 2023 3 -$164K 4 Jun 22, 2023 EVP, Chief Technical Officer
NTLA Intellia Therapeutics, Inc. Mar 1, 2023 3 $0 4 Mar 3, 2023 EVP, Chief Technical Officer
NTLA Intellia Therapeutics, Inc. Jul 1, 2022 3 -$76.4K 4 Jan 6, 2023 EVP, Chief Technical Officer
NTLA Intellia Therapeutics, Inc. Mar 1, 2022 2 $0 4 Mar 7, 2022 EVP, Chief Technical Officer
NTLA Intellia Therapeutics, Inc. Feb 23, 2022 0 $0 3 Mar 7, 2022 EVP, Chief Technical Officer